Inhibition of hemorragic snake venom components: Old and new approaches

Toxins

Volumn 2, Issue 4, 2010, Pages 417-427

  Panfoli, Isabella ^a   Calzia, Daniela ^a   Ravera, Silvia ^a   Morelli, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antivenins; Direct electric current; Etnomedicine; Metalloprotease; Phosphodiesterase; Phospholipase A2; Snake venom

Indexed keywords

CASEARIA MARIQUITENSIS EXTRACT; EPEMA; METAL CHELATE; PENTACLETHRA MACROLOBA EXTRACT; PHOSPHOLIPASE A2 INHIBITOR; PLANT EXTRACT; SCHIZOLOBIUM PARAHYBA EXTRACT; SNAKE VENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG;

BLOOD TOXICITY; CASEARIA; CASEARIA MARIQUITENSIS; DIRECT CURRENT; DRUG MECHANISM; ELECTROSTIMULATION THERAPY; ENVENOMATION; ENZYME ACTIVITY; ENZYME MECHANISM; FIRST AID; GEOGRAPHIC DISTRIBUTION; HEMOSTASIS; HUMAN; IMMOBILIZATION; MEDICINAL PLANT; NONHUMAN; PENTACLETHRA MACROLOBA; POISONOUS SNAKE; PROTEIN STABILITY; REVIEW; SCHIZOLOBIUM PARAHYBA; SNAKEBITE; TOXIN ANALYSIS; TRADITIONAL MEDICINE; TRANSCUTANEOUS NERVE STIMULATION;

ANIMALS; ANTIVENINS; ELECTRIC STIMULATION THERAPY; HEMORRHAGE; HUMANS; METALLOPROTEASES; PHOSPHOLIPASES A2; PLANT EXTRACTS; SNAKE BITES; SNAKE VENOMS;

VIPERIDAE;

EID: 78349297916     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins2040417     Document Type: Review

References (59)

1. Bieber, A.L. Snake Venoms: Metal and Nonprotein Constituents in Snake Venoms; Springer- Verlag: Berlin, Germany, 1979; Volume 52, pp. 295-306.
2. Mebs, D. Venomous and Poisonous Animals: A Handbook for Biologists, Toxicologists and Toxinologists, Physicians and Pharmacists; CRC Press, Medpharm Scientific Publishers: Stuttgart, Germany, 2002; pp. 238-256.
3. Aird, S.D. Ophidian envenomation strategies and the role of purines. Toxicon 2002, 40, 335-393.
4. W.H.O. Progress in the Characterization of Venoms and Standardization of Antivenoms; Offset Publication ed., World Health Organization: Geneva, Switzerland, 1981; Volume 58.
5. Warrell, D.A.; Fenner, P.J. Venomous bites and stings. Br. Med. Bull. 1993, 49, 423-439.
6. Chippaux, J.P. Snake-bites: appraisal of the global situation. Bull. World Health Organiz. 1998, 76, 515-524.
7. Trape, J.F.; Pison, G.; Guyavarch, E.; Mane, Y. High mortality from snakebite in south-eastern Senegal. Trans. R. Soc. Trop. Med. Hyg. 2001, 95, 420-423.
8. Theakston, R.D.; Warrell, D.A.; Griffiths, E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003, 41, 541-557.
9. Lalloo, D.G.; Trevett, A.J.; Saweri, A.; Naraqi, S.; Theakston, R.D.; Warrell, D.A. The epidemiology of snake bite in Central Province and National Capital District, Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 1995, 89, 178-182.
10. Gold, B.S.; Dart, R.C.; Barish, R.A. Bites of venomous snakes. New Engl. J. Med. 2002, 347, 347-356.
11. Peterson, M.E. Snake bite: pit vipers. Clin. Tech. Small Anim. Pract. 2006, 21, 174-182.
12. Nazim, M.H.; Gupta, S.; Hashmi, S.; Zuberi, J.; Wilson, A.; Roberts, L.; Karimi, K. Retrospective review of snake bite victims. W. V. Med. J. 2008, 104, 30-34.
13. Persson, H. Envenoming by European vipers antivenom treatment--influence on morbidity. Przegl. Lek. 2001, 58, 223-225.
14. Warrell, D.A. Commissioned article: management of exotic snakebites. QJM 2009, 102, 593-601.
15. Juarez, P.; Sanz, L.; Calvete, J.J. Snake venomics: characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N-terminal sequencing, and tandem mass spectrometry analysis. Proteomics 2004, 4, 327-338.
16. Fox, J.W.; Serrano, S.M. Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures. Proteomics 2008, 8, 909-920.
17. Andrews, R.K.; Berndt, M.C. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 2000, 38, 775-791.
18. Koh, D.C.; Armugam, A.; Jeyaseelan, K. Snake venom components and their applications in biomedicine. Cell. Mol. Life Sci. 2006, 63, 3030-3041.
19. Hodgson, W.C.; Wickramaratna, J.C. In vitro neuromuscular activity of snake venoms. Clin. Exp. Pharmacol. Physiol. 2002, 29, 807-814.
20. Balsinde, J.; Winstead, M.V.; Dennis, E.A. Phospholipase A(2) regulation of arachidonic acid mobilization. FEBS Lett. 2002, 531, 2-6.
21. Diaz, B.L.; Arm, J.P. Phospholipase A(2). Prostaglandins Leukot. Essent. Fatty Acids 2003, 69, 87-97.
22. Kini, R.M. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem. J. 2006, 397, 377-387.
23. Kini, R.M.; Evans, H.J. A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon 1989, 27, 613-635.
24. Kini, R.M. Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms. Toxicon 2005, 45, 1147-1161.
25. Kamiguti, A.S.; Hay, C.R.; Theakston, R.D.; Zuzel, M. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 1996, 34, 627-642.
26. de Roodt, A.R.; Litwin, S.; Vidal, J.C. Hemorrhagic activity of Bothrops venoms determined by two different methods and relationship with proteolytic activity on gelatin and lethality. Toxicon 2003, 41, 949-958.
27. Stocker, W.; Grams, F.; Baumann, U.; Reinemer, P.; Gomis-Ruth, F.X.; McKay, D.B.; Bode, W. The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 1995, 4, 823-840.
28. Zhang, D.; Botos, I.; Gomis-Ruth, F.X.; Doll, R.; Blood, C.; Njoroge, F.G.; Fox, J.W.; Bode, W.; Meyer, E.F. Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). Proc.Natl. Acad. Sci. USA 1994, 91, 8447-8451.
29. Hite, L.A.; Fox, J.W.; Bjarnason, J.B. A new family of proteinases is defined by several snake venom metalloproteinases. Biol. Chem. Hoppe Seyler. 1992, 373, 381-385.
30. Bjarnason, J.B.; Tu, A.T. Hemorrhagic toxins from Western diamondback rattlesnake (Crotalus atrox) venom: isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin e. Biochemistry 1978, 17, 3395-3404.
31. Nikai, T.; Mori, N.; Kishida, M.; Sugihara, H.; Tu, A.T. Isolation and biochemical characterization of hemorrhagic toxin f from the venom of Crotalus atrox (western diamondback rattlesnake). Arch. Biochem. Biophys. 1984, 231, 309-319.
32. Juckett, G.; Hancox, J.G. Venomous snakebites in the United States: management review and update. Am. Fam. Physician. 2002, 65, 1367-1374.
33. Araujo, A.S.; Lobato, Z.I.; Chavez-Olortegui, C.; Velarde, D.T. Brazilian IgY-Bothrops antivenom: Studies on the development of a process in chicken egg yolk. Toxicon 2009, 55, 739-744.
34. Soares, A.M.; Ticli, F.K.; Marcussi, S.; Lourenco, M.V.; Januario, A.H.; Sampaio, S.V.; Giglio, J.R.; Lomonte, B.; Pereira, P.S. Medicinal plants with inhibitory properties against snake venoms. Curr. Med. Chem. 2005, 12, 2625-2641.
35. Marcussi, S.; Sant'Ana, C.D.; Oliveira, C.Z.; Rueda, A.Q.; Menaldo, D.L.; Beleboni, R.O.; Stabeli, R.G.; Giglio, J.R.; Fontes, M.R.; Soares, A.M. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. Curr. Top. Med. Chem. 2007, 7, 743-756.
36. da Silva, J.O.; Coppede, J.S.; Fernandes, V.C.; Sant'ana, C.D.; Ticli, F.K.; Mazzi, M.V.; Giglio, J.R.; Pereira, P.S.; Soares, A.M.; Sampaio, S.V. Antihemorrhagic, antinucleolytic and other antiophidian properties of the aqueous extract from Pentaclethra macroloba. J. Ethnopharmacol. 2005, 100, 145-152.
37. Vale, L.H.; Mendes, M.M.; Hamaguchi, A.; Soares, A.M.; Rodrigues, V.M.; Homsi-Brandeburgo, M.I. Neutralization of pharmacological and toxic activities of bothrops snake venoms by Schizolobium parahyba (Fabaceae) aqueous extract and its fractions. Basic Clin. Pharmacol. Toxicol. 2008, 103, 104-107.
38. Izidoro, L.F.; Rodrigues, V.M.; Rodrigues, R.S.; Ferro, E.V.; Hamaguchi, A.; Giglio, J.R.; Homsi-Brandeburgo, M.I. Neutralization of some hematological and hemostatic alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi pauloensis snake venom, by the aqueous extract from Casearia mariquitensis (Flacourtiaceae). Biochimie 2003, 85, 669-675.
39. Sanchez, E.E.; Lopez-Johnston, J.C.; Rodriguez-Acosta, A.; Perez, J.C. Neutralization of two North American coral snake venoms with United States and Mexican antivenoms. Toxicon 2008, 51, 297-303.
40. Faure, G. Natural inhibitors of toxic phospholipases A(2). Biochimie 2000, 82, 833-840.
41. Thwin, M.M.; Gopalakrishnakone, P.; Kini, R.M.; Armugam, A.; Jeyaseelan, K. Recombinantantitoxic and antiinflammatory factor from the nonvenomous snake Python reticulatus: phospholipase A2 inhibition and venom neutralizing potential. Biochemistry2000,39, 9604-9611.
42. Dunn, R.D.; Broady, K.W. Snake inhibitors of phospholipase A(2) enzymes. Biochim. Biophys. Acta 2001, 1533, 29-37.
43. Kihara, H. Studies on phospholipase A in Trimeresurus flaoviridis venom. III. Purification and some properties of phospholipase A inhibitor in Habu serum. J. Biochem. 1976, 80, 341-349.
44. Soares, A.M.; Marcussi, S.; Stabeli, R.G.; Franca, S.C.; Giglio, J.R.; Ward, R.J.; Arantes, E.C. Structural and functional analysis of BmjMIP, a phospholipase A2 myotoxin inhibitor protein from Bothrops moojeni snake plasma. Biochem. Biophys. Res. Commun. 2003, 302, 193-200.
45. Biardi, J.E.; Coss, R.G.; Smith, D.G. California ground squirrel (Spermophilus beecheyi) blood sera inhibits crotalid venom proteolytic activity. Toxicon 2000, 38, 713-721.
46. Guderian, R.H.; Mackenzie, C.D.; Williams, J.F. High voltage shock treatment for snake bite. Lancet 1986, 2, 229.
47. McPartland, J.M.; Foster, R. Stun-guns and snakebites. Lancet 1988, 2, 1141.
48. Kroegel, C.; Meyer zum Buschenfelde, K.H. Biological basis for high-voltage-shock treatment for snakebite. Lancet 1986, 2, 1335.
49. Dart, R.C.; Gustafson, R.A. Failure of electric shock treatment for rattlesnake envenomation. Ann. Emergency Med. 1991, 20, 659-661.
50. Rushton, D.N. Electrical stimulation in the treatment of pain. Disab. Rehabil. 2002, 24, 407-415.
51. Calzia, D.; Panfoli, I.; Ravera, S.; Dazzi, E.; Gandolfo, S.; Pepe, I.M.; Vergani, L.; Morelli, A.M. Structural modification of proteins by direct electric current from low voltage. J. Biochem. Mol. Toxicol. 2009, 23, 309-317.
52. Panfoli, I.; Ravera, S.; Calzia, D.; Dazzi, E.; Gandolfo, S.; Pepe, I.M.; Morelli, A. Inactivation of phospholipase A(2) and metalloproteinase from Crotalus atrox venom by direct current. J. Biochem. Mol. Toxicol. 2007, 21, 7-12.
53. Wang, W.J.; Huang, T.F. Purification and characterization of a novel metalloproteinase, acurhagin, from Agkistrodon acutus venom. Thromb. Haemost. 2002, 87, 641-650.
54. Francis, B.; Seebart, C.; Kaiser, II Citrate is an endogenous inhibitor of snake venom enzymes by metal-ion chelation. Toxicon 1992, 30, 1239-1246.
55. Gutierrez, J.M.; Rucavado, A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 2000, 82, 841-850.
56. Suhre, K.; Claverie, J.M. Genomic correlates of hyperthermostability, an update. J. Biol. Chem. 2003, 278, 17198-17202.
57. Petrovic, U.; Sribar, J.; Paris, A.; Rupnik, M.; Krzan, M.; Vardjan, N.; Gubensek, F.; Zorec, R.; Krizaj, I. Ammodytoxin, a neurotoxic secreted phospholipase A(2), can act in the cytosol of the nerve cell. Biochem. Biophys. Res. Commun. 2004, 324, 981-985.
58. Kumar, S.; Nussinov, R. How do thermophilic proteins deal with heat? Cell. Mol. Life Sci. 2001, 58, 1216-1233.
59. Yano, J.K.; Poulos, T.L. New understandings of thermostable and peizostable enzymes. Curr. Opin. Biotechnol. 2003, 14, 360-365.